Rising care costs Average out-of-pocket costs associated with rebates were highest for uninsured patients ($39), followed by Medicare patients ($13), and then those with commercial insurance ($6). (Photo: Shutterstock)

Drug rebates for insurers often are associated with increases in out-of-pocket costs for patients, according to a new University of Washington study that examined cost and price data on more than 400 branded drugs.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.